Ascendis Pharma A's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2025 to a ratio of 8.48, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the fourth quarter 2025. Average receivable collection period, for the Ascendis Pharma A in Dec 31 2025 quarter, has decreased to 43 days, compared to 64 days, in the 0 quarter.

If we take a look into Healthcare sector 269 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2025 from 0 to 2926.

What is Receivable Turnover Ratio?
What is Ascendis Pharma A Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ASND Receivables Turnover Ratio	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Receivable Change	-15 %	-15 %	-15 %	-15 %	1296.14 %
Y / Y Revenue Change	98.03 %	292.89 %	362.52 %	2.14 %	610.6 %
Receivable Turnover Ratio (TTM)	8.48	5.7	4.39	3.44	3.3
ASND's Total Ranking	# 2926	# 0	#	#	#
Accounts Receivable average collection period days	43	64	83	106	111
Seq. Receivable Change	0 %	0 %	0 %	-15 %	0 %
Seq. Revenue Change	223.08 %	39.27 %	68.6 %	-73.9 %	540.98 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 72
Healthcare Sector	# 270
Overall Market	# 2926

Receivable Turnover Ratio Statistics
High	Average	Low
0.55	0.14	0.01
(Dec 31 2025)		(Dec 31 2020)

ASND Company Profile • Back to ASND Efficiency Comparisons • Compare ASND Receivables Turnover Ratio to its Competitors

Financial Statements
Ascendis Pharma A's Accounts Receivable	$ 158 Millions	Visit ASND's Balance sheet
Ascendis Pharma A's Sales TTM	$ 1,342 Millions	Visit ASND's Income Statement
Sources of ASND's Revenues		Visit ASND's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ASND's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ASND's Growth Rates	ASND's Roa	ASND's Inventory Turnover Ratio	ASND's Dividend Comparisons
ASND's Profitability Ratios	ASND's Roi	ASND's Asset Turnover Ratio	ASND's Dividend Growth
ASND's Valuation Ratios	ASND's Roe	ASND's Financial Strength Ratios	ASND's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2025	Receivable at quarter ending Dec 31 2025
Valneva Se	23.01	$ 195.618 Millions	$ 8.501 Millions
Longeveron Inc	22.20	$ 1.199 Millions	$ 0.054 Millions
Lifemd Inc	21.48	$ 193.686 Millions	$ 9.018 Millions
Fonar Corporation	21.42	$ 106.031 Millions	$ 4.950 Millions
Neuraxis Inc	21.11	$ 3.569 Millions	$ 0.169 Millions
Biorestorative Therapies Inc	20.88	$ 0.360 Millions	$ 0.017 Millions
Arvinas Inc	19.93	$ 262.600 Millions	$ 13.175 Millions
Sonida Senior Living Inc	19.55	$ 381.141 Millions	$ 19.494 Millions
Siga Technologies Inc	19.47	$ 94.575 Millions	$ 4.856 Millions
Kiniksa Pharmaceuticals International Plc	19.45	$ 677.564 Millions	$ 34.828 Millions
Lipocine Inc	18.38	$ 1.977 Millions	$ 0.108 Millions
Wave Life Sciences Ltd	18.34	$ 59.102 Millions	$ 3.223 Millions
Vystar Corporation	18.31	$ 0.055 Millions	$ 0.003 Millions
Nurix Therapeutics Inc	17.68	$ 83.980 Millions	$ 4.750 Millions
Icecure Medical Ltd	17.17	$ 3.379 Millions	$ 0.197 Millions
Marpai Inc	16.64	$ 18.099 Millions	$ 1.088 Millions
Euda Health Holdings Limited	16.07	$ 5.993 Millions	$ 0.373 Millions
Bioage Labs Inc	16.01	$ 8.995 Millions	$ 0.562 Millions
Nutriband Inc	15.64	$ 2.037 Millions	$ 0.130 Millions
Plus Therapeutics Inc	15.53	$ 5.213 Millions	$ 0.336 Millions
Talkspace Inc	15.35	$ 228.871 Millions	$ 14.915 Millions
Nanobiotix S a	15.26	$ 36.504 Millions	$ 2.392 Millions
Gsk Plc	15.21	$ 32,667.000 Millions	$ 2,148.000 Millions
Precipio inc	15.02	$ 24.049 Millions	$ 1.601 Millions
Qhslab Inc	14.47	$ 2.692 Millions	$ 0.186 Millions
Arbutus Biopharma Corp	14.04	$ 14.083 Millions	$ 1.003 Millions
Sutro Biopharma Inc	13.92	$ 102.484 Millions	$ 7.365 Millions
Aim Immunotech Inc	13.54	$ 0.088 Millions	$ 0.007 Millions
Amneal Pharmaceuticals Inc	13.44	$ 3,018.308 Millions	$ 224.629 Millions
Inmed Pharmaceuticals Inc	13.26	$ 4.507 Millions	$ 0.340 Millions

Date modified: 2026-07-07T09:17:02+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.